CAPSTONE INVESTMENT ADVISORS, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 24 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$21,706,546
+138.6%
10,082,000
+98.4%
0.07%
+106.1%
Q1 2024$9,096,780
+26.4%
5,082,0000.0%0.03%
+50.0%
Q4 2023$7,197,637
-19.9%
5,082,0000.0%0.02%
-45.0%
Q3 2023$8,984,976
+4.7%
5,082,0000.0%0.04%
-4.8%
Q2 2023$8,580,143
-37.4%
5,082,000
-28.2%
0.04%
-39.1%
Q1 2023$13,695,632
-24.7%
7,080,000
-51.2%
0.07%
-22.5%
Q2 2022$18,198,000
-4.5%
14,500,0000.0%0.09%
+71.2%
Q1 2022$19,049,00014,500,0000.05%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 61,662,000$141,593,0005.18%
WOLVERINE ASSET MANAGEMENT LLC 93,891,000$215,954,0002.17%
LINDEN ADVISORS LP 30,877,000$71,021,0001.15%
Verition Fund Management LLC 14,948,000$34,343,0001.13%
SSI INVESTMENT MANAGEMENT LLC 5,167,000$11,858,0001.04%
TENOR CAPITAL MANAGEMENT Co., L.P. 7,500,000$17,246,0000.78%
ADVENT CAPITAL MANAGEMENT /DE/ 11,929,000$27,313,0000.64%
CSS LLC/IL 4,144,000$9,531,0000.54%
AQR Arbitrage LLC 4,625,000$10,626,0000.47%
Calamos Advisors LLC 25,136,000$57,829,0000.41%
View complete list of SAREPTA THERAPEUTICS INC shareholders